5Jung M C, Gruner N, Zachoval R, et al. Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine specific CD4+ T-cell proliferative response in chronic hepatitis B carriers. Vaccine.2002, 20: 3598-3612.
6Wands JR, Liang TS, Blum HE, Shafritz DA.Molecular pathogenesis of liver disease during persistent hepatitis B virus infection. Semin Liver Dis, 1992, 12 (3):252-264.
7Rajcani J, Mosko T, Rezuchoval. Current developments in viral DNA vaccines: shall they solve the unsolved[J].Rev Med Virol, 2005,15:303~325.
8Gish RG.Current treatment and future directions in the management of chronic hepatitis B viral infection[J].Clin Liver Dis, 2005, 9:541-565.
9ImanmraT,ArakiM,MiyanoharaA,NakaoJ,YonemuraH,OhtomoN,MatsubaraK. Expression Of hepatitis B virus middle and large surface antigen genes in Saccharomyees cerevisiae [J].Virol 1987,61:3543-3549.
10BrussV, VielufK.Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis [J].Virol1995,69:6652-6657.
